Artificial intelligence and clinical data analytics services company BullFrog AI, and the Lieber Institute for Brain Development, an independent, not-for-profit medical research institute working to accelerate efforts to find new cures for developmental brain disorders, have signed a joint collaboration to apply BullFrog AI’s artificial intelligence platform to analyze anti-psychotic drug responses.

Under the terms of the agreement, BullFrog AI will utilize their AI platform to analyze large multi-factorial clinical data sets from patients who received antipsychotic medication.

[Image courtesy: Lieber Institute for Brain Development]